Global law firm Norton Rose Fulbright announced the addition of prominent partners John Bonnet III and Mark Pendleton to its Dallas office, continuing the expansion of its corporate, M&A, and securities practice. The pair are joined by senior counsel Larry McFarland and associate Hannah Choi, strengthening the firm’s capabilities in private equity, healthcare, and energy transactions.
The firm’s corporate, M&A, and securities group includes 450 partners and 700 additional deal lawyers advising on complex transactions worldwide. In 2026, Norton Rose Fulbright has accelerated growth in its business transactions practice with the addition of eight U.S. partners, including a five-partner team specializing in corporate, private equity, healthcare, finance, and tax matters.
John Bonnet III brings decades of experience advising on mergers and acquisitions, debt and equity financings, investment funds, commercial lending, corporate governance, and general business transactions. His client base spans startups, investment fund sponsors, strategic and passive investors, boards of directors, and executive leadership teams. He also advises companies on strategic alliances and capital access through equity and debt offerings.
Mark Pendleton focuses his practice on company and asset sales, mergers, financing transactions, private equity structures, corporate governance, regulatory matters, and joint ventures. His experience is concentrated in private equity, healthcare, and energy, with clients including investors, independent sponsors, management service organizations, hospitals, physician groups, ambulatory surgery centers, and healthcare startups.
The group joins from Bradley Arant Boult Cummings LLP, where Bonnet previously served as managing partner of the Dallas office. Both Bonnet and Pendleton are licensed to practice in Texas.
KEY QUOTES:
“Our business practice group prides itself on helping clients successfully get complex high-value deals across the finish line. With John’s substantial corporate M&A practice and Mark’s experience in the healthcare industry, our Dallas office is gaining a dynamic pair of business-minded legal practitioners with deep roots in the city.”
Jeff Cody, US Managing Partner And Global Managing Partner, Norton Rose Fulbright
“We know that our clients are approaching M&A differently in light of global trade uncertainty and regulatory hurdles, and that requires increased adaptability and strategic planning. John and Mark have proven to be trusted advisors who structure sophisticated deals to achieve their clients’ business objectives.”
Scarlet McNellie, US Co-Head Of Corporate, M&A And Securities, Norton Rose Fulbright
“Norton Rose Fulbright’s corporate practice offers top-tier service to clients while also supporting the growth of its lawyers. I am excited for my clients to receive the benefits of this firm’s global reach, deep industry knowledge and focus on excellence.”
John Bonnet III, Partner, Norton Rose Fulbright
“The reputation of the firm’s healthcare law practice, with its deep bench in both transactional and regulatory work, was a key driver in my decision to join Norton Rose Fulbright. I am eager to work with this impressive team of M&A-focused lawyers and those practicing in all aspects of healthcare law.”
Mark Pendleton, Partner, Norton Rose Fulbright
